<DOC>
	<DOCNO>NCT01492192</DOCNO>
	<brief_summary>The goal clinical research study look 2 new method scan see whether help researcher predict tumour respond drug attack tumour blood supply .</brief_summary>
	<brief_title>RGD-PET-CT Cancer Angiogenesis</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Angiogenesis Inhibitors</mesh_term>
	<criteria>1 . Patients advance metastatic RCC confirm histological diagnosis 2 . Patients consider suitable therapy TKI RCC accord responsible clinician 3 . Measurable tumour accord RECIST v1.1 criterion 4 . Standard stag CT scan perform within 28 day first research scan 5 . The patient receive chemotherapy , radiotherapy , surgery treatment cancer within 4 week prior recruitment 6 . Age â‰¥18 year 7 . Adequate renal function ( creatinine &lt; 1.25xULN ) 8 . Patient able tolerate comply scan procedure 9 . Patient lactate pregnant 10 . Absence psychological , familial , sociological geographical condition opinion Investigator may potentially hamper compliance study protocol followup schedule ; condition discuss patient registration trial 11 . Able willing give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Angiogenesis</keyword>
	<keyword>PET-CT</keyword>
	<keyword>Perfusion-CT</keyword>
</DOC>